MCKEON BRIAN P 4
4 · IDEXX LABORATORIES INC /DE · Filed Feb 18, 2025
Insider Transaction Report
Form 4
MCKEON BRIAN P
Director
Transactions
- Exercise/Conversion
Common Stock
2025-02-14+299→ 32,118.593 total - Tax Payment
Common Stock
2025-02-14$444.53/sh−569$252,938→ 31,549.593 total - Exercise/Conversion
Common Stock
2025-02-14+252→ 31,208.593 total - Exercise/Conversion
Common Stock
2025-02-14+303→ 31,511.593 total - Exercise/Conversion
Common Stock
2025-02-14+308→ 31,819.593 total - Exercise/Conversion
Restricted Stock Unit
2025-02-14−303→ 303 total→ Common Stock (303 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-14−308→ 615 total→ Common Stock (308 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-14−299→ 894 total→ Common Stock (299 underlying) - Exercise/Conversion
Restricted Stock Unit
2025-02-14−252→ 0 total→ Common Stock (252 underlying)
Holdings
- 18,050(indirect: By LLC)
Common Stock
Footnotes (5)
- [F1]Includes a total of 25 shares purchased under the Issuer's Employee Stock Purchase Plan on September 30, 2024 and December 31, 2024.
- [F2]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2022.
- [F3]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2023.
- [F4]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning February 14, 2024.
- [F5]Each RSU represents a contingent right to receive one share of Issuer common stock and vested in four annual installments, beginning on February 14, 2025.